Stimulation of Met triggers the activation of multiple downstream signaling cascades, predominantly the MAPK/ERK1/2 and PI3K/Akt signaling axes, which are critically involved in promoting tumor cell proliferation, survival, and invasiveness [75]. The gene discussed is MAPK3; the disease is neoplasm.